KB001
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for KB001, covering 2009-07-31 to 2011-08-08. Get the full timeline:
Most recent: Clinical Trial Update: Dose Escalation Study of KB001 in Cystic Fibrosis Patients Infected With Pseudomonas Aeruginosa [Phase 1, Phase 2]